U.S., Nov. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07918677) titled 'Food Supplement for Individuals With Polygenic Hypercholesterolaemia' on Nov. 01.
Brief Summary: Atherogenic dyslipidaemia is a key modifiable determinant of cardiovascular risk. Non-HDL-C provides a comprehensive estimate of atherogenic cholesterol burden. In primary prevention, adults with polygenic hypercholesterolaemia often require dietary and lifestyle interventions, but these may not yield sufficient lipid improvements.
This study evaluates the efficacy of a combined nutraceutical (phytosterols + bergamot dry extract + artichoke dry extract) and phytosterols alone, versus placebo, on non-HDL-C change in adults with polygenic ...